Analysis of Risk Factors and Mortality of Patients with Carbapenem-Resistant Klebsiella pneumoniae Infection

References

• Lee BY, Bartsch SM, Wong KF, et al. The potential trajectory of carbapenem-resistant Enterobacteriaceae, an emerging threat to health-care facilities, and the impact of the centers for disease control and prevention toolkit. Am J Epidemiol. 2016;183(5):471–479. doi:10.1093/aje/kwv299
   Web of Science ®Google Scholar
• Brink AJ. Epidemiology of carbapenem-resistant gram-negative infections globally. Curr Opin Infect Dis. 2019;32(6):609–616. doi:10.1097/qco.0000000000000608
   PubMed Web of Science ®Google Scholar
• Munoz-Price LS, Poirel L, Bonomo RA, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013;13(9):785–796. doi:10.1016/s1473-3099(13)70190-7
   PubMed Web of Science ®Google Scholar
• Bialek-Davenet S, Criscuolo A, Ailloud F, et al. Genomic definition of hypervirulent and multidrug-resistant Klebsiella pneumoniae clonal groups. Emerg Infect Dis. 2014;20(11):1812–1820. doi:10.3201/eid2011.140206
   PubMed Web of Science ®Google Scholar
• Feng Y, Lu Y, Yao Z, Zong Z. Carbapenem-resistant hypervirulent Klebsiella pneumoniae of sequence type 36. Antimicrob Agents Chemother. 2018;62(7). doi:10.1128/aac.02644-17
   Web of Science ®Google Scholar
• Huang W, Qiao F, Zhang Y, et al. In-hospital medical costs of infections caused by carbapenem-resistant Klebsiella pneumoniae. Clin Infect Dis. 2018;67(suppl_2):S225–s230. doi:10.1093/cid/ciy642
   PubMed Web of Science ®Google Scholar
• He G, Huang J, Huang S, et al. Risk factors affecting clinical outcome in patients with carbapenem-resistant k. Pneumoniae: a retrospective study. Med Sci Monit. 2020;26:e925693. doi:10.12659/msm.925693
   Web of Science ®Google Scholar
• Qian Y, Bi Y, Liu S, Li X, Dong S, Ju M. Predictors of mortality in patients with carbapenem-resistant Klebsiella pneumoniae infection: a meta-analysis and a systematic review. Ann Palliat Med. 2021;10(7):7340–7350. doi:10.21037/apm-21-338
   PubMed Web of Science ®Google Scholar
• Bratu S, Landman D, Haag R, et al. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York city: a new threat to our antibiotic armamentarium. Arch Intern Med. 2005;165(12):1430–1435. doi:10.1001/archinte.165.12.1430
   PubMed Web of Science ®Google Scholar
• Gasink LB, Edelstein PH, Lautenbach E, Synnestvedt M, Fishman NO. Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing k. Pneumoniae. Infect Control Hosp Epidemiol. 2009;30(12):1180–1185. doi:10.1086/648451
   PubMed Web of Science ®Google Scholar
• Xu L, Sun X, Ma X. Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae. Ann Clin Microbiol Antimicrob. 2017;16(1):18. doi:10.1186/s12941-017-0191-3
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing: twenty-four informational supplement. CLSI document m100-s24; 2014.
   Google Scholar
• Kollef MH, Micek ST. Strategies to prevent antimicrobial resistance in the intensive care unit. Crit Care Med. 2005;33(8):1845–1853. doi:10.1097/01.ccm.0000171849.04952.79
   Web of Science ®Google Scholar
• Jacobs DM, Safir MC, Huang D, Minhaj F, Parker A, Rao GG. Triple combination antibiotic therapy for carbapenemase-producing Klebsiella pneumoniae: a systematic review. Ann Clin Microbiol Antimicrob. 2017;16(1):76. doi:10.1186/s12941-017-0249-2
   Web of Science ®Google Scholar
• Igbinosa O, Dogho P, Osadiaye N. Carbapenem-resistant Enterobacteriaceae: a retrospective review of treatment and outcomes in a long-term acute care hospital. Am J Infect Control. 2020;48(1):7–12. doi:10.1016/j.ajic.2019.07.006
   Web of Science ®Google Scholar
• del Mar Tomas M, Cartelle M, Pertega S, et al. Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection. Clin Microbiol Infect. 2005;11(7):540–546. doi:10.1111/j.1469-0691.2005.01184.x
   PubMed Web of Science ®Google Scholar
• Pan H, Lou Y, Zeng L, et al. Infections caused by carbapenemase-producing Klebsiella pneumoniae: microbiological characteristics and risk factors. Microb Drug Resist. 2019;25(2):287–296. doi:10.1089/mdr.2018.0339
   Web of Science ®Google Scholar
• Liu J, Wang H, Huang Z, et al. Risk factors and outcomes for carbapenem-resistant Klebsiella pneumoniae bacteremia in onco-hematological patients. J Infect Dev Ctries. 2019;13(5):357–364. doi:10.3855/jidc.11189
   Web of Science ®Google Scholar
• Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother. 2008;52(3):1028–1033. doi:10.1128/aac.01020-07
   PubMed Web of Science ®Google Scholar
• Tian L, Tan R, Chen Y, et al. Epidemiology of Klebsiella pneumoniae bloodstream infections in a teaching hospital: factors related to the carbapenem resistance and patient mortality. Antimicrob Resist Infect Control. 2016;5:48. doi:10.1186/s13756-016-0145-0
   PubMed Web of Science ®Google Scholar
• Giannella M, Trecarichi EM, De Rosa FG, et al. Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study. Clin Microbiol Infect. 2014;20(12):1357–1362. doi:10.1111/1469-0691.12747
   PubMed Web of Science ®Google Scholar
• Gómez Rueda V, Zuleta Tobón JJ. Risk factors for infection with carbapenem-resistant Klebsiella pneumoniae: a case-case-control study. Colomb Med. 2014;45(2):54–60. doi:10.25100/cm.v45i2.1417
   Web of Science ®Google Scholar
• Martin RM, Cao J, Brisse S, et al. Molecular epidemiology of colonizing and infecting isolates of Klebsiella pneumoniae. MSphere. 2016;1(5). doi:10.1128/mSphere.00261-16
   PubMed Web of Science ®Google Scholar
• Gorrie CL, Mirceta M, Wick RR, et al. Gastrointestinal carriage is a major reservoir of Klebsiella pneumoniae infection in intensive care patients. Clin Infect Dis. 2017;65(2):208–215. doi:10.1093/cid/cix270
   PubMed Web of Science ®Google Scholar
• Xiao T, Zhu Y, Zhang S, et al. A retrospective analysis of risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae bacteremia in nontransplant patients. J Infect Dis. 2020;221(Suppl 2):S174–s183. doi:10.1093/infdis/jiz559
   PubMed Web of Science ®Google Scholar
• Satlin MJ, Calfee DP, Chen L, et al. Emergence of carbapenem-resistant Enterobacteriaceae as causes of bloodstream infections in patients with hematologic malignancies. Leuk Lymphoma. 2013;54(4):799–806. doi:10.3109/10428194.2012.723210
   PubMed Web of Science ®Google Scholar
• Freire MP, Pierrotti LC, Filho HH, et al. Infection with Klebsiella pneumoniae carbapenemase (kpc)-producing Klebsiella pneumoniae in cancer patients. Eur J Clin Microbiol Infect Dis. 2015;34(2):277–286. doi:10.1007/s10096-014-2233-5
   PubMed Web of Science ®Google Scholar
• Ramos-Castañeda JA, Ruano-Ravina A, Barbosa-Lorenzo R, et al. Mortality due to kpc carbapenemase-producing Klebsiella pneumoniae infections: systematic review and meta-analysis: mortality due to kpc Klebsiella pneumoniae infections. J Infect. 2018;76(5):438–448. doi:10.1016/j.jinf.2018.02.007
   PubMed Web of Science ®Google Scholar
• Dai G, Xu Y, Kong H, Xie W, Wang H. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection and associated clinical outcomes. Am J Transl Res. 2021;13(6):7276–7281.
   PubMed Web of Science ®Google Scholar
• Zhang F, Zhong J, Ding H, et al. Analysis of risk factors for carbapenem-resistant Klebsiella pneumoniae infection and its effect on the outcome of early infection after kidney transplantation. Front Cell Infect Microbiol. 2021;11:726282. doi:10.3389/fcimb.2021.726282
   PubMed Web of Science ®Google Scholar